Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC

Sun Yat-sen University · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
hepatocellular-carcinoma
hepatocellular carcinoma, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 906552
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.